• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对甲氧西林敏感血流感染门诊患者使用达托霉素的评估。

Evaluation of Daptomycin Use in Outpatients With Methicillin-Sensitive Bloodstream Infections.

作者信息

Kener Daisy, Childress Darrell, Andrus Ian, Olson Jared, Webb Brandon

机构信息

Department of Pharmacy, Intermountain Health Utah-St George Regional Hospital, St George, Utah, USA.

Department of Pharmacy, Intermountain Health Utah-Primary Children's Hospital, Salt Lake City, Utah, USA.

出版信息

Open Forum Infect Dis. 2025 Jan 17;12(2):ofaf012. doi: 10.1093/ofid/ofaf012. eCollection 2025 Feb.

DOI:10.1093/ofid/ofaf012
PMID:39896981
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11786053/
Abstract

Multiple observational studies in methicillin-resistant and enterococcal infections have suggested that higher doses of daptomycin may be associated with better clinical outcomes. However, optimal daptomycin dosing in methicillin-sensitive bloodstream infections remains unclear. In this multicentered, retrospective, observational cohort study, we compared standard dose daptomycin (<8 mg/kg) vs high dose (≥8 mg/kg) for methicillin-sensitive bloodstream infections. In a propensity-weighted model, the composite outcome of treatment failure within 90 days was lower in the high-dose group relative to the standard dose group (odds ratio, 0.496; 95% CI, .306-.804). We did not detect any significant difference in safety outcomes.

摘要

多项针对耐甲氧西林和肠球菌感染的观察性研究表明,较高剂量的达托霉素可能与更好的临床结果相关。然而,对于甲氧西林敏感的血流感染,达托霉素的最佳剂量仍不清楚。在这项多中心、回顾性、观察性队列研究中,我们比较了甲氧西林敏感血流感染患者使用标准剂量(<8mg/kg)与高剂量(≥8mg/kg)达托霉素的情况。在倾向加权模型中,高剂量组90天内治疗失败的复合结局低于标准剂量组(优势比,0.496;95%CI,0.306 - 0.804)。我们未发现安全结局有任何显著差异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47da/11786053/ce8293d30a78/ofaf012f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47da/11786053/ce8293d30a78/ofaf012f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47da/11786053/ce8293d30a78/ofaf012f1.jpg

相似文献

1
Evaluation of Daptomycin Use in Outpatients With Methicillin-Sensitive Bloodstream Infections.对甲氧西林敏感血流感染门诊患者使用达托霉素的评估。
Open Forum Infect Dis. 2025 Jan 17;12(2):ofaf012. doi: 10.1093/ofid/ofaf012. eCollection 2025 Feb.
2
Daptomycin Improves Outcomes Regardless of Vancomycin MIC in a Propensity-Matched Analysis of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.在一项针对耐甲氧西林金黄色葡萄球菌血流感染的倾向性匹配分析中,无论万古霉素最低抑菌浓度如何,达托霉素均可改善治疗结果。
Antimicrob Agents Chemother. 2016 Sep 23;60(10):5841-8. doi: 10.1128/AAC.00227-16. Print 2016 Oct.
3
Daptomycin Plus β-Lactam Combination Therapy for Methicillin-resistant Staphylococcus aureus Bloodstream Infections: A Retrospective, Comparative Cohort Study.达托霉素联合β-内酰胺类药物治疗耐甲氧西林金黄色葡萄球菌血流感染:一项回顾性、对比队列研究。
Clin Infect Dis. 2020 Jun 24;71(1):1-10. doi: 10.1093/cid/ciz746.
4
Comparative Effectiveness of Vancomycin Versus Daptomycin for MRSA Bacteremia With Vancomycin MIC >1 mg/L: A Multicenter Evaluation.万古霉素对最低抑菌浓度>1mg/L的耐甲氧西林金黄色葡萄球菌菌血症的疗效与达托霉素的比较:一项多中心评估。
Clin Ther. 2016 Jan 1;38(1):16-30. doi: 10.1016/j.clinthera.2015.09.017. Epub 2015 Nov 14.
5
Adjunctive Daptomycin in the Treatment of Methicillin-susceptible Staphylococcus aureus Bacteremia: A Randomized, Controlled Trial.辅助达托霉素治疗耐甲氧西林金黄色葡萄球菌菌血症:一项随机对照试验。
Clin Infect Dis. 2021 May 4;72(9):e196-e203. doi: 10.1093/cid/ciaa1000.
6
High MICs for Vancomycin and Daptomycin and Complicated Catheter-Related Bloodstream Infections with Methicillin-Sensitive Staphylococcus aureus.万古霉素和达托霉素的高最低抑菌浓度以及耐甲氧西林金黄色葡萄球菌引起的复杂导管相关血流感染
Emerg Infect Dis. 2016 Jun;22(6):1057-66. doi: 10.3201/eid2206.151709.
7
Clinical Outcomes of Daptomycin Versus Anti-Staphylococcal Beta-Lactams in Definitive Treatment of Methicillin-susceptible Staphylococcus aureus Bloodstream Infections.达托霉素与抗葡萄球菌β-内酰胺类药物在治疗耐甲氧西林金黄色葡萄球菌血流感染中的临床结局比较。
Int J Antimicrob Agents. 2021 Aug;58(2):106363. doi: 10.1016/j.ijantimicag.2021.106363. Epub 2021 May 24.
8
Are there differences in hospital cost between patients with nosocomial methicillin-resistant Staphylococcus aureus bloodstream infection and those with methicillin-susceptible S. aureus bloodstream infection?耐甲氧西林金黄色葡萄球菌医院血流感染患者与甲氧西林敏感金黄色葡萄球菌血流感染患者之间的住院费用有差异吗?
Infect Control Hosp Epidemiol. 2009 May;30(5):453-60. doi: 10.1086/596731.
9
Multicenter Cohort Study of Ceftaroline Versus Daptomycin for Treatment of Methicillin-Resistant Bloodstream Infection.头孢洛林与达托霉素治疗耐甲氧西林血流感染的多中心队列研究
Open Forum Infect Dis. 2021 Dec 23;9(3):ofab606. doi: 10.1093/ofid/ofab606. eCollection 2022 Mar.
10
Vancomycin versus daptomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteremia due to isolates with high vancomycin minimum inhibitory concentrations: study protocol for a phase IIB randomized controlled trial.万古霉素与达托霉素治疗万古霉素最低抑菌浓度较高的耐甲氧西林金黄色葡萄球菌菌血症:一项IIB期随机对照试验的研究方案
Trials. 2014 Jun 19;15:233. doi: 10.1186/1745-6215-15-233.

引用本文的文献

1
Antimicrobial peptide biological activity, delivery systems and clinical translation status and challenges.抗菌肽的生物活性、递送系统以及临床转化现状与挑战。
J Transl Med. 2025 Mar 7;23(1):292. doi: 10.1186/s12967-025-06321-9.

本文引用的文献

1
Therapeutic Options for Adult Patients With Persistent Methicillin-Susceptible Bacteremia: A Narrative Review.耐甲氧西林敏感金黄色葡萄球菌菌血症成人患者的治疗选择:一篇叙述性综述。
Ann Pharmacother. 2023 Nov;57(11):1312-1327. doi: 10.1177/10600280231158809. Epub 2023 Mar 22.
2
Comparison of the efficacy and safety of standard- and high-dose daptomycin: A systematic review and meta-analysis.标准剂量与高剂量达托霉素疗效与安全性的比较:系统评价与荟萃分析。
Br J Clin Pharmacol. 2023 Apr;89(4):1291-1303. doi: 10.1111/bcp.15671. Epub 2023 Feb 13.
3
bacteraemia and mortality: a population-based study in Olmsted County, Minnesota, from 2006 to 2020.
血流感染和死亡率:2006 年至 2020 年明尼苏达州奥姆斯特德县的一项基于人群的研究。
Infect Dis (Lond). 2023 Jan;55(1):1-8. doi: 10.1080/23744235.2022.2123561. Epub 2022 Sep 24.
4
Multicenter Cohort Study of Ceftaroline Versus Daptomycin for Treatment of Methicillin-Resistant Bloodstream Infection.头孢洛林与达托霉素治疗耐甲氧西林血流感染的多中心队列研究
Open Forum Infect Dis. 2021 Dec 23;9(3):ofab606. doi: 10.1093/ofid/ofab606. eCollection 2022 Mar.
5
Clinical Outcomes of Daptomycin Versus Anti-Staphylococcal Beta-Lactams in Definitive Treatment of Methicillin-susceptible Staphylococcus aureus Bloodstream Infections.达托霉素与抗葡萄球菌β-内酰胺类药物在治疗耐甲氧西林金黄色葡萄球菌血流感染中的临床结局比较。
Int J Antimicrob Agents. 2021 Aug;58(2):106363. doi: 10.1016/j.ijantimicag.2021.106363. Epub 2021 May 24.
6
Bacteremia due to Methicillin-Resistant Staphylococcus aureus: An Update on New Therapeutic Approaches.耐甲氧西林金黄色葡萄球菌引起的菌血症:新治疗方法的最新进展。
Infect Dis Clin North Am. 2020 Dec;34(4):849-861. doi: 10.1016/j.idc.2020.04.003. Epub 2020 Sep 30.
7
Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia: A Randomized Clinical Trial.万古霉素或达托霉素联合与不联合抗葡萄球菌β-内酰胺类药物治疗耐甲氧西林金黄色葡萄球菌菌血症患者的死亡率、菌血症、复发或治疗失败的影响:一项随机临床试验。
JAMA. 2020 Feb 11;323(6):527-537. doi: 10.1001/jama.2020.0103.
8
Association of daptomycin dosing regimen and mortality in patients with VRE bacteraemia: a review.万古霉素耐药肠球菌菌血症患者的达托霉素给药方案与死亡率的相关性:综述。
J Antimicrob Chemother. 2018 Sep 1;73(9):2277-2283. doi: 10.1093/jac/dky072.
9
Association of Higher Daptomycin Dose (7 mg/kg or Greater) with Improved Survival in Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia.高剂量达托霉素(7mg/kg 或更高)与耐甲氧西林金黄色葡萄球菌菌血症患者生存率提高的相关性。
Pharmacotherapy. 2018 Feb;38(2):189-196. doi: 10.1002/phar.2070. Epub 2018 Jan 8.
10
Survival from methicillin-sensitive Staphylococcus aureus bloodstream infections over 20 years: a cohort of 1328 patients.20年间耐甲氧西林金黄色葡萄球菌血流感染患者的生存情况:1328例患者队列研究
Swiss Med Wkly. 2017 Sep 30;147:w14508. doi: 10.4414/smw.2017.14508. eCollection 2017.